ATH alterity therapeutics limited

ANN meeting 225, page-5

  1. 138 Posts.
    lightbulb Created with Sketch. 55
    Great find Pivalde. Yeah agree Scott, it sounds from the final sentence Efficacy, biomarker and safety data will be available in Q12025 and will be presented, they'll likely present the further analysis at ANN 2025 April 5-9? Just 3 weeks away! if so it will time nicely with vote out of the way hopefully allowing SP to appreciate if the market likes what is presented. Fantastic news.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.001(11.1%)
Mkt cap ! $91.27M
Open High Low Value Volume
0.9¢ 1.0¢ 0.9¢ $41.54K 4.357M

Buyers (Bids)

No. Vol. Price($)
35 11136808 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 4729475 10
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.